These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 7296626)
1. Rat serum factors inhibiting the G1-S transition in hepatocytes. I. Production of a low molecular weight inhibitor by proteases or liver fractions. Nadal C; Le Rumeur E; Boffa GA Cell Tissue Kinet; 1981 Nov; 14(6):601-9. PubMed ID: 7296626 [TBL] [Abstract][Full Text] [Related]
2. [Demonstration in human plasma of 2 factors inhibiting hepatocyte multiplication by blocking the cell cycle at the level of G1-S transition]. Rius E; Nadal C; Boffa GA C R Acad Sci III; 1984; 299(5):119-22. PubMed ID: 6432231 [TBL] [Abstract][Full Text] [Related]
3. Rat serum factors inhibiting the G1-S transition in hepatocytes. II. Properties of the low molecular weight factor. Le Rumeur E; Winchenne JJ; Boffa GA; Nadal C Cell Tissue Kinet; 1983 Jul; 16(4):333-42. PubMed ID: 6861192 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of human alpha 2-macroglobulin and a peptide released by trypsin, on the G1-S transition of hepatocytes in vivo]. Boffa GA; Lambin P; Rius E; Nadal C C R Acad Sci III; 1985; 300(2):31-6. PubMed ID: 2578862 [TBL] [Abstract][Full Text] [Related]
5. [Release from human alpha 2-macroglobulin of a peptide inhibitor of G1-S transition of hepatocytes in vivo. Role of trypsin, thrombin and various chemical agents]. Lambin P; Nadal C; Winchenne JJ; Boffa GA C R Acad Sci III; 1987; 304(19):477-80. PubMed ID: 2438019 [TBL] [Abstract][Full Text] [Related]
6. Characterization of alphaA-crystallin from high molecular weight aggregates in the normal human lens. Fujii N; Awakura M; Takemoto L; Inomata M; Takata T; Fujii N; Saito T Mol Vis; 2003 Jul; 9():315-22. PubMed ID: 12847419 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions. McIntyre M; Desdouets C; Sénamaud-Beaufort C; Laurent-Winter C; Lamas E; Bréchot C Oncogene; 1999 Aug; 18(32):4577-85. PubMed ID: 10467402 [TBL] [Abstract][Full Text] [Related]
8. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. Yamada H; Toda G; Yoshiba M; Hashimoto N; Ikeda Y; Mitsui H; Kurokawa K; Sugata F; Hughes RD; Williams R Hepatology; 1994 May; 19(5):1133-40. PubMed ID: 8175134 [TBL] [Abstract][Full Text] [Related]
9. Purification and partial characterization of a hepatocyte antiproliferative glycopeptide. Auger G; Blanot D; van Heijenoort J; Nadal C; Gournay MF; Winchenne JJ; Boffa GA; Lambin P; Maes P; Tartar A J Cell Biochem; 1989 Aug; 40(4):439-51. PubMed ID: 2476452 [TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Fan G; Ma X; Kren BT; Steer CJ Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852 [TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity studies of 2-Chloronitrobenzene (CAS No. 88-73-3) and 4-Chloronitrobenzene (CAS No. 100-00-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice. Bucher J Toxic Rep Ser; 1993 Jul; 33():1-F25. PubMed ID: 12209191 [TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
14. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. Harada N; Okajima K; Uchiba M Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616 [TBL] [Abstract][Full Text] [Related]
15. Role of the kidney in the expression of low molecular weight factors with growth factor activity. Jacob C; Maachi F; el Farricha O; Dousset B; Kessler M; Belleville F; Nabet P Clin Nephrol; 1993 Jun; 39(6):327-34. PubMed ID: 8334760 [TBL] [Abstract][Full Text] [Related]
16. Nongenotoxic carcinogens shift cultured rat hepatocytes into G1 cell cycle phase: influence of tissue oxygen tension on cells with different ploidy. Duivenvoorden WC; Maier P Eur J Cell Biol; 1994 Aug; 64(2):368-75. PubMed ID: 7813522 [TBL] [Abstract][Full Text] [Related]
17. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. Yasuda H; Mine T; Shibata H; Eto Y; Hasegawa Y; Takeuchi T; Asano S; Kojima I J Clin Invest; 1993 Sep; 92(3):1491-6. PubMed ID: 8376601 [TBL] [Abstract][Full Text] [Related]
18. Putrescine as a comitogen of epidermal growth factor in rat liver growth. Nagoshi S; Fujiwara K Hepatology; 1994 Sep; 20(3):725-30. PubMed ID: 8076929 [TBL] [Abstract][Full Text] [Related]
19. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116 [TBL] [Abstract][Full Text] [Related]
20. Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells. Derenzini M; Montanaro L; Chillà A; Tosti E; Vici M; Barbieri S; Govoni M; Mazzini G; Treré D J Cell Physiol; 2005 Feb; 202(2):483-91. PubMed ID: 15389582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]